4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-21-066004
Director bought 1,430 shares at an average $35.09 ($50,181)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2021-11-18 | Purchase | +409 | $35.07 | $14,344 | 421,407 | I |
| Coleman Mark Director | 2021-11-18 | Purchase | +1,021 | $35.10 | $35,837 | 422,428 | I |
| Open-market purchases · 1,430 sh · avg $35.09 · $50,181 | |||||||
Loading xslF345X03/doc4.xml…